Shattuck Labs, Inc. logo

STTK Earnings Date: Nov 10, 2026 (Estimated) — Shattuck Labs, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $5.51
Market Cap $553.5M
P/E -10.6
52W Range $1.72 – $8.33
Next Earnings · Before open (est.)

When is STTK's next earnings date?

Shattuck Labs, Inc. (STTK) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.10 on revenue of $33,333.

How did STTK do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Shattuck Labs, Inc. posted EPS of -$0.12 versus the -$0.12 estimate, a beat of 7.7%. Revenue was $0. The stock's 1-day post-earnings move was +0.6%.

How much does STTK stock move after earnings?

STTK beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.4% (up or down) in the day after earnings.

About Shattuck Labs, Inc.

Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.12-0.12+7.69%$0✅ Beat+0.56%+3.50%-11.34%
2026-05-07Q1 2026-0.13-0.13+0.00%$0➖ Inline-6.29%+1.05%-31.44%
2026-03-05Q4 2025-0.13-0.12+7.69%$0✅ Beat+7.82%+24.31%+35.73%
2025-11-06Q3 2025-0.15-0.14+6.67%$1.0M✅ Beat-3.92%-5.88%+51.96%
2025-08-14Q2 2025-0.25-0.24+4.00%$0✅ Beat+6.13%+24.58%+136.83%
2025-03-27Q4 2024-0.32-0.37-15.62%$0❌ Miss-3.39%-16.64%-32.51%
2024-11-14Q3 2024-0.42-0.33+21.43%$3.0M✅ Beat+12.30%-9.02%-6.56%
2024-08-01Q2 2024-0.41-0.42-2.44%$1.6M❌ Miss-3.18%-19.10%-4.77%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .